Surender Khurana

InstitutionCenter for Biologics Evaluation and Research
AddressSilver Spring
Maryland
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in February 2021 and June 2021 and July 2021
    All Publications
    Bar chart showing 65 publications over 16 distinct years, with a maximum of 9 publications in 2011 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tang J, Grubbs G, Lee Y, Golding H, Khurana S. Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients. Clin Infect Dis. 2022 01 29; 74(2):327-334. PMID: 33861337.
      Citations: 2     Fields:    
    2. Tang J, Lee Y, Ravichandran S, Grubbs G, Huang C, Stauft CB, Wang T, Golding B, Golding H, Khurana S. Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern. iScience. 2021 Sep 24; 24(9):103006. PMID: 34430803.
      Citations: 1     
    3. Prahlad J, Struble LR, Lutz WE, Wallin SA, Khurana S, Schnaubelt A, Broadhurst MJ, Bayles KW, Borgstahl GEO. CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain. Protein Sci. 2021 09; 30(9):1983-1990. PMID: 34191362.
      Citations: 1     Fields:    Translation:HumansCells
    4. Golding B, Lee Y, Golding H, Khurana S. Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report. Ann Rheum Dis. 2021 10; 80(10):1359-1361. PMID: 34272252.
      Citations:    Fields:    Translation:Humans
    5. Hahn G, Wu CM, Lee S, Lutz SM, Khurana S, Baden LR, Haneuse S, Qiao D, Hecker J, DeMeo DL, Tanzi RE, Choudhary MC, Etemad B, Mohammadi A, Esmaeilzadeh E, Cho MH, Li JZ, Randolph AG, Laird NM, Weiss ST, Silverman EK, Ribbeck K, Lange C. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain. Genet Epidemiol. 2021 10; 45(7):685-693. PMID: 34159627.
      Citations: 1     Fields:    Translation:Humans
    6. Patel PA, Lapp SA, Grubbs G, Edara VV, Rostad CA, Stokes CL, Pauly MG, Anderson EJ, Piantadosi A, Suthar MS, Khurana S, Sabnis HS. Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19. Br J Haematol. 2021 08; 194(3):549-553. PMID: 34096051.
      Citations:    Fields:    Translation:Humans
    7. Citations: 28     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    8. Ravichandran S, Lee Y, Grubbs G, Coyle EM, Klenow L, Akasaka O, Koga M, Adachi E, Saito M, Nakachi I, Ogura T, Baba R, Ito M, Kiso M, Yasuhara A, Yamada S, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Yamayoshi S, Yotsuyanagi H, Kawaoka Y, Khurana S. Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution. Sci Adv. 2021 03; 7(10). PMID: 33674317.
      Citations: 6     Fields:    Translation:HumansCells
    9. Tang J, Ravichandran S, Lee Y, Grubbs G, Coyle EM, Klenow L, Genser H, Golding H, Khurana S. Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients. Nat Commun. 2021 02 22; 12(1):1221. PMID: 33619281.
      Citations: 7     Fields:    Translation:Humans
    10. Sagar S, Rathinavel AK, Lutz WE, Struble LR, Khurana S, Schnaubelt AT, Mishra NK, Guda C, Palermo NY, Broadhurst MJ, Hoffmann T, Bayles KW, Reid SPM, Borgstahl GEO, Radhakrishnan P. Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein. Clin Transl Med. 2021 02; 11(2):e281. PMID: 33635001.
      Citations: 2     Translation:HumansAnimalsCells
    11. Ravichandran S, Coyle EM, Klenow L, Tang J, Grubbs G, Liu S, Wang T, Golding H, Khurana S. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits. Sci Transl Med. 2020 07 01; 12(550). PMID: 32513867.
      Citations: 65     Fields:    Translation:AnimalsPHPublic Health
    Khurana's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (135)
    Explore
    _
    Co-Authors (139)
    Explore
    _
    Similar People (60)
    Explore
    _